TELA Bio, Inc. (TELA)
NASDAQ: TELA · Real-Time Price · USD
0.8299
+0.0518 (6.66%)
At close: Mar 23, 2026, 4:00 PM EDT
0.8281
-0.0018 (-0.22%)
Pre-market: Mar 24, 2026, 8:24 AM EDT
TELA Bio Employees
TELA Bio had 209 employees as of December 31, 2024. The number of employees decreased by 18 or -7.93% compared to the previous year.
Employees
209
Change (1Y)
-18
Growth (1Y)
-7.93%
Revenue / Employee
$368,684
Profits / Employee
-$186,593
Market Cap
33.48M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2024 | 209 | -18 | -7.93% |
| Dec 31, 2023 | 227 | 54 | 31.21% |
| Dec 31, 2022 | 173 | 50 | 40.65% |
| Dec 31, 2021 | 123 | 15 | 13.89% |
| Dec 31, 2020 | 108 | 19 | 21.35% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Nortech Systems | 744 |
| Myomo | 195 |
| Cytosorbents | 149 |
| IRIDEX | 93 |
| Adagio Medical Holdings | 80 |
| VolitionRx | 75 |
| Pulsenmore | 58 |
| Inspira Technologies Oxy B.H.N. | 45 |
TELA News
- 13 days ago - TELA Bio to Announce Fourth Quarter and Full Year 2025 Financial Results - GlobeNewsWire
- 4 weeks ago - TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 4 months ago - TELA Bio to Participate in the Piper Sandler 37th Annual Healthcare Conference - GlobeNewsWire
- 4 months ago - These Analysts Cut Their Forecasts On TELA Bio After Q3 Earnings - Benzinga
- 4 months ago - TELA Bio Announces Pricing of $13.0 Million Underwritten Registered Direct Offering of Common Stock and Pre-Funded Warrants - GlobeNewsWire
- 4 months ago - TELA Bio Reports Third Quarter 2025 Financial Results and Refinancing and Upsizing of Credit Facility - GlobeNewsWire
- 5 months ago - TELA Bio Announces Addition of Betty Jo Rocchio to Board of Directors and the Departure of Director Lisa Colleran - GlobeNewsWire
- 8 months ago - TELA Bio Reports Second Quarter 2025 Financial Results - GlobeNewsWire